The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
Pangea will use its integrated validation platform and regulatory expertise to oversee analytical and clinical validation of Gene Solutions’ multi-omics technologies.
Subscribe To Our Newsletter & Stay Updated
